English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 859767 線上人數 : 820
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
癌症研究所
于重元
劉柯俊
劉滄梧
劉界元(2003-2010)
夏和雄(1996-2012)
夏興國
姜乃榕
常慧如
張俊彥
張光裕
張憶壽
張文祥
張書銘
彭汪嘉康(1996-2007)
施能耀
李家惠
李岳倫
林素芳
楊奕馨
江士昇
沈哲宏
洪文俊
莊雙恩
蔡坤志
蔡慧珍
蘇勇曄
蘇振良
郭靜娟
陳尚鴻
陳振陽
陳立宗
陳美霞(2002-2009)
陳詩政
陳雅雯
黃智興
黃道揚
丁兆治(2000-2004)
其他
劉敏(1996-2007)
劉玫英(2004-2006)
吳成文(1996-2008)
曾思文(1997-2007)
李冠德(1997-2004)
林景太(1999-2007)
楊文光(1996-1999)
王全正(1996-2003)
莊聲宏(1997-2004)
詹宗晃(2000-2008)
賴基銘(2004-2008)
阮麗蓉(2000-2006)
陳俊叡(2003-2007)
馬彥英(1997-1999)
黃奇英(2005-2007)
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
癌症研究所
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
社群詳細資訊
簡介:
NA
資料載入中.....
子社群
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
66
/71]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
鄰近社群
分子與基因醫學研究所
[
921
/964]
生技與藥物研究所
[
830
/1008]
生醫工程與奈米醫學研究所
[
1214
/1334]
免疫醫學研究中心
[
224
/236]
神經及精神醫學研究中心
[
782
/804]
細胞及系統醫學研究所
[
755
/815]
感染症與疫苗研究所
[
1541
/1618]
群體健康科學研究所
[
2870
/3000]
國家環境醫學研究所
[
1560
/1591]
國家蚊媒傳染病防治研究中心
[
102
/104]
高齡醫學暨健康福祉研究中心
[
216
/224]
論壇
[
2
/2]
生醫資源中心
[
7
/7]
研究生培育合作學程
[
188
/191]
核心儀器設施中心
[
9
/9]
病理核心實驗室
[
14
/14]
實驗動物中心
[
8
/8]
行政管理部門
[
18
/18]
社群統計
近3年內發表的文件:335(13.91%)
含全文筆數:2250(93.40%)
文件下載次數統計
下載大於0次:2250(100.00%)
下載大於100次:2250(100.00%)
檔案下載總次數:1611277(30.06%)
最後更新時間: 2024-11-28 18:37
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Pathological response following neo...
Registry of genetic alterations of ...
Activated single nucleotide mismatc...
Taiwan nationwide study of first-li...
The effectiveness of virtual passpo...
Special Issue "Bioinformatics ...
Evaluating a natural language proce...
The clinicopathological significanc...
Hypoxia in drug resistance and radi...
DKK1 as a chemoresistant protein mo...
跳至:
(選擇年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目251-275 / 2409. (共97頁)
<<
<
6
7
8
9
10
11
12
13
14
15
>
>>
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2022-07-21
Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation
Journal of Translational Medicine. 2022 Jul 21;20:Article number 324.
2022-07-15
Association of dietary pattern with cardiovascular risk factors among postmenopausal women in Taiwan: A cross-sectional study from 2001 to 2015
Nutrients. 2022 Jul 15;14(14):Article number 2911.
2022-07-13
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma
Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220.
2022-07-01
PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan
npj Genomic Medicine. 2022 Jul 01;7:Article number 40.
2022-07
Toward collaboration among cancer trials groups in Asia: TCOG perspective
Annals of Oncology. 2022 Jul;33(Suppl. 6):S449.
2022-07
Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience
Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
2022-07
Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
Annals of Oncology. 2022 Jul;33(Suppl. 6):S484.
2022-07
A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer
Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
2022-06-30
Upregulation of cartilage oligomeric matrix protein predicts poor prognosis in urothelial carcinoma
OncoTargets and Therapy. 2022 Jun 30;15:727-740.
2022-06-26
The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer
Cancers. 2022 Jun 26;14(13):Article number 3137.
2022-06-22
Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study
Frontiers in Oncology. 2022 Jun 22;12:Article number 800842.
2022-06-16
Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study
Therapeutic Advances in Medical Oncology. 2022 Jun 16;14:1-13.
2022-06-06
Protected health information recognition of unstructured code-mixed electronic health records in Taiwan
Studies in Health Technology and Informatics. 2022 Jun 6;290:627-631.
2022-06-02
Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: A cohort study
Nutrition and Cancer. 2022 Jun 2;74(10):3546-3555.
2022-06-02
Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma
Journal of Hepatocellular Carcinoma. 2022 Jun 2;9:517-536.
2022-06
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
Journal of Hepato-Biliary-Pancreatic Sciences. 2022 Jun;54(5):607-612.
2022-06
Clinical implications of differential functional capacity between tissue-specific human mesenchymal stromal/stem cells
The FEBS Journal. 2023 Jun;290(11):2833-2844.
2022-06
Role of high ubiquitin-conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma
Oncology Letters. 2022 Jun;23(6):Article number 194.
2022-06
MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/beta-catenin pathway
Journal of Biomedical Science. 2022 Jun;29:Article number 42.
2022-06
Effects of harassment on psychological inflexibility/experiential avoidance among Taiwanese emergent adult gay and bisexual men
Journal of the Formosan Medical Association. 2022 Jun;121(7):1302-1309.
2022-06
Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma
Journal of Clinical Oncology. 2022 Jun;40(16, Suppl.):Abstract number 4120.
2022-06
Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements
Journal of Clinical Oncology. 2022 Jun;40(16, Suppl.):Abstract number 4009.
2022-05-23
A prospective preventive screening tool-pancreatic cancer risk model developed by AI technology C3 - lecture notes in electrical engineering
Lecture Notes in Electrical Engineering. 2022 May 23;827:159-166.
2022-05-20
Combined low plant and high animal dietary pattern is associated with a lower risk of anemia among dyslipidemic adult women in Taiwan: A retrospective study from 2001 to 2015
International Journal of Environmental Research and Public Health. 2022 May 20;19(10):Article number 6231.
2022-05-15
Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients
American Journal of Cancer Research. 2022 May 15;12(5):2084-2101.
顯示項目251-275 / 2409. (共97頁)
<<
<
6
7
8
9
10
11
12
13
14
15
>
>>
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋